Sanara Medtech Valuation
| SMTI Stock | USD 33.64 0.74 2.25% |
At this time, the company appears to be undervalued. Sanara Medtech has a current Real Value of $40.56 per share. The regular price of the company is $33.64. Our model measures the value of Sanara Medtech from inspecting the company fundamentals such as Shares Outstanding of 8.74 M, return on equity of -0.2, and Operating Margin of (0.06) % as well as reviewing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Sanara Medtech's price fluctuation is very steady at this time. Calculation of the real value of Sanara Medtech is based on 3 months time horizon. Increasing Sanara Medtech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Sanara Medtech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sanara Stock. However, Sanara Medtech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 33.64 | Real 40.56 | Hype 33.69 | Naive 34.46 |
The intrinsic value of Sanara Medtech's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Sanara Medtech's stock price.
Estimating the potential upside or downside of Sanara Medtech helps investors to forecast how Sanara stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sanara Medtech more accurately as focusing exclusively on Sanara Medtech's fundamentals will not take into account other important factors: Sanara Medtech Total Value Analysis
Sanara Medtech is at this time anticipated to have valuation of 298.25 M with market capitalization of 287.58 M, debt of 11.79 M, and cash on hands of 12.68 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Sanara Medtech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
298.25 M | 287.58 M | 11.79 M | 12.68 M |
Sanara Medtech Investor Information
About 67.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.99. Sanara Medtech last dividend was issued on the 10th of May 2019. The entity had 1:100 split on the 10th of May 2019. Sanara Medtech is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Sanara Medtech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sanara Medtech has an asset utilization ratio of 87.98 percent. This signifies that the Company is making $0.88 for each dollar of assets. An increasing asset utilization means that Sanara Medtech is more efficient with each dollar of assets it utilizes for everyday operations.Sanara Medtech Ownership Allocation
The market capitalization of Sanara Medtech is $287.58 Million. Sanara Medtech has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 66.75 % of Sanara Medtech outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Sanara Medtech Profitability Analysis
The company reported the previous year's revenue of 64.99 M. Net Loss for the year was (4.3 M) with profit before overhead, payroll, taxes, and interest of 70.38 M.About Sanara Medtech Valuation
An absolute valuation paradigm, as applied to Sanara Stock, attempts to find the value of Sanara Medtech based on its fundamental and basic technical indicators. By analyzing Sanara Medtech's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Sanara Medtech's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sanara Medtech. We calculate exposure to Sanara Medtech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sanara Medtech's related companies.Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas. Sanara Medtech operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 63 people.
Sanara Medtech Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 8.3 M |
Complementary Tools for Sanara Stock analysis
When running Sanara Medtech's price analysis, check to measure Sanara Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanara Medtech is operating at the current time. Most of Sanara Medtech's value examination focuses on studying past and present price action to predict the probability of Sanara Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanara Medtech's price. Additionally, you may evaluate how the addition of Sanara Medtech to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |